Specific immunosorbents in diagnosis and management of myasthenia gravis.
Maelicke
A
A
Max-Planck-Institut für Ernährungsphysiologie, Dortmund, Federal Republic of Germany.
Yang
B H
BH
Sundaram
P V
PV
Fels
G
G
D000818:Animals; D001323:Autoantibodies / Q000032:analysis* / Q000378:metabolism; D002846:Chromatography, Affinity; D003039:Cobra Neurotoxin Proteins / Q000378:metabolism; D006801:Humans; D007163:Immunosorbent Techniques; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000276:immunology*; D009757:Nylons; D011817:Rabbits; D011950:Receptors, Cholinergic / Q000276:immunology* / Q000378:metabolism; D012710:Serum Albumin, Bovine / Q000378:metabolism; D014101:Torpedo
D001323:Autoantibodies; D003039:Cobra Neurotoxin Proteins; D009757:Nylons; D011950:Receptors, Cholinergic; D012710:Serum Albumin, Bovine; C025154:alpha-cobratoxin